Tectonic Therapeutic (TECX) Total Liabilities (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Total Liabilities of $16.2 million for Q1 2026, up 17.16% year-over-year from $13.8 million in Q1 2025, and up 66.44% quarter-over-quarter from $9.7 million in Q4 2025.
Analysis
Tectonic Therapeutic (TECX) Total Liabilities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Total Liabilities for 10 consecutive years, with $16.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 17.16% year-over-year to $16.2 million; the TTM figure through Mar 2026 stood at $16.2 million (up 17.16% YoY), while the FY2025 annual figure was $9.7 million, down 19.95% from the prior year.
- Total Liabilities improved to $16.2 million in Q1 2026 per TECX's latest filing, from $9.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $43.4 million in Q4 2023 and bottomed at $3.5 million in Q1 2024.
- Historically, Total Liabilities has averaged $19.7 million across 5 years, with a median of $16.2 million in 2026.
- Annual changes were most pronounced in 2024 — Total Liabilities sank 88.31% — and 2025, when it soared 293.07%.
- Tectonic Therapeutic's Total Liabilities stood at $28.6 million in 2022, then soared by 51.89% to $43.4 million in 2023, then tumbled by 72.06% to $12.1 million in 2024, then decreased by 19.95% to $9.7 million in 2025, then jumped by 66.44% to $16.2 million in 2026.
- Business Quant data shows TECX's Total Liabilities at $16.2 million in Q1 2026, $9.7 million in Q4 2025, and $9.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 13.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.19 Mn |
| Mar 31, 2026 | 16.16 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 13.79 Mn |
| Dec 31, 2024 | 12.13 Mn |
| Sep 30, 2024 | 18.36 Mn |
| Jun 30, 2024 | 27.54 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 43.41 Mn |
| Sep 30, 2023 | 7.66 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 30.01 Mn |
| Dec 31, 2022 | 28.58 Mn |
| Sep 30, 2022 | 31.41 Mn |
| Jun 30, 2022 | 27.90 Mn |
| Mar 31, 2022 | 32.18 Mn |
| Dec 31, 2021 | 34.36 Mn |
| Sep 30, 2021 | 22.88 Mn |